| |
|
|
|
Aldeyra Therapeu  
|
|
4.92 0.2 (0.04%) |
05-29 16:00 |
|
Open: |
4.75 |
Pre close: |
4.72 |
Target:
|
6.09 
|
|
High: |
5.215 |
Low: |
4.72 |
Resistance:
|
5.22
6.09
|
|
Volume: |
1,918,887 |
Market Cap: |
147M |
Support:
|
3.59
2.58
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.44
|
MACD |
MACD(12,26):
|
0.46 |
|
MA(20): |
3.71 |
Signal(12,26,9): |
0.36 |
|
MA(100): |
3.91  |
Stochastic Oscillator |
%K(14,3):
|
79.59 |
|
MA(250): |
5.00 |
%D(3): |
71.41 |
|
Average Volume(K) |
3-Month: |
63536
|
52-Week |
High:
|
8.05 |
|
10-Days: |
196170 |
Low: |
1.48 |
|
RSI |
RSI(14):
|
69.81 |
Change(%): |
-26.8 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.992 |
Return on Equity (ttm) |
-90.3 |
Shares Out. (M) |
29.79 |
|
EPS Est. Current Year |
-1.470 |
Return on Assets (ttm) |
-45.7 |
Shares Float (M) |
22.19 |
|
EPS Est. Next Year |
-1.740 |
PEG Ratio |
0.00 |
% Held by Insiders |
4.01 |
|
EPS Est. Next Quarter |
-0.370 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
65.87 |
|
Forward EPS |
-2.240 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
484 |
|
Book Value (p.s.) |
1.470 |
EBITDA (p.s.) |
-1.852 |
P/E |
-2.47 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
3.35 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-47.71 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-11.74 |
P/CF |
-3.07 |
|
|
|
|
|
|
